Aqemia accelerates drug discovery using quantum physics and AI, generating novel drug candidates without experimental data.
AQEMIA has raised $7.4M in total funding. The most recent round was Grant. The last funding was announced in April 2025.
AQEMIA's investors include Bpifrance, Cathay Innovation, Eurazeo, Elaia, France 2030.
AQEMIA is headquartered in Paris, France.
Aqemia accelerates drug discovery using quantum physics and AI, generating novel drug candidates without experimental data.
AQEMIA is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"AQEMIA — Funding & Investors." VCBacked, April 1, 2025, https://www.vcbacked.co/company/aqemia. Accessed July 31, 2026.
VCBacked. (2025). AQEMIA — Funding & Investors. Retrieved July 31, 2026, from https://www.vcbacked.co/company/aqemia
{{cite web |title=AQEMIA — Funding & Investors |url=https://www.vcbacked.co/company/aqemia |website=VCBacked |access-date=July 31, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated